2014 Highlights of ASH in North America Meeting

Emerging effective treatment options for salvage therapy in Hodgkin lymphoma were described by Anas Younes, MD, Chief of the Lymphoma Service at Memorial Sloan Kettering Cancer Center, New York, at th...

myelodysplastic syndromes

Caroline Helwick / May 15, 2014 / 2014 Highlights of ASH in North America Meeting

Forward Progress in Myelodysplastic Syndromes Is Largely in Genetics

Most recent advances in the management of myelodysplastic syndrome (MDS) are in the area of genetics, according to Steven Gore, MD, of Yale University School of Medicine, New Haven. “New genomics res...

Nov

Today In Oncology

Treatment With ADT May Be Linked to Higher Risk of Heart Failure in Patients With Prostate Cancer

ACS Report Looks at Ways to Improve Outcomes for Cancer Survivors and Caregivers

Lorlatinib Shows Overall and Intracranial Activity in ALK-Positive NSCLC

Sequential vs Combination Fluoropyrimidine, Irinotecan, and Bevacizumab in Metastatic Colorectal Cancer

Adverse Mental Health Outcomes in Breast Cancer Survivors

;

2014 Highlights of ASH in North America Meeting

Better Options Emerging for Salvage Therapy in Hodgkin Lymphoma

Forward Progress in Myelodysplastic Syndromes Is Largely in Genetics

Treatment With ADT May Be Linked to Higher Risk of Heart Failure in Patients With Prostate Cancer

ACS Report Looks at Ways to Improve Outcomes for Cancer Survivors and Caregivers

Lorlatinib Shows Overall and Intracranial Activity in ALK-Positive NSCLC

Sequential vs Combination Fluoropyrimidine, Irinotecan, and Bevacizumab in Metastatic Colorectal Cancer

Adverse Mental Health Outcomes in Breast Cancer Survivors

Prevalence of Lynch Syndrome in Solid Tumors According to Microsatellite Instability Status

2018 Palliative Care: Immunotherapy-Related Adverse Events May Be More Common Than Initially Reported

FDA Approves Pembrolizumab for Hepatocellular Carcinoma Previously Treated With a Kinase Inhibitor

Neoadjuvant Chemotherapy With vs Without Anthracyclines Plus Dual HER2 Inhibitors in HER2-Positive Breast Cancer

Cost of Cancer Care in Community vs Hospital Settings

Caroline Robert, MD, PhD, on Advanced Melanoma: Research Highlights

Laurence Albiges, MD, PhD, on RCC: Challenging Established Front-Line Treatment

Arti Hurria, MD, on Survivorship Care for the Aging Population

Peter Schmid, MD, PhD, on Triple-Negative Breast Cancer: Results From the PAKT Trial

Alexander M.M. Eggermont, MD, PhD, on Melanoma: Advances in Adjuvant Therapy